AstraZeneca
AstraZeneca PLC: A British-Swedish firm specializing in research, manufacturing, and sales of pharmaceuticals.
Founded
1999AstraZeneca PLC: A British-Swedish firm specializing in research, manufacturing, and sales of pharmaceuticals.
Founded on April 6, 1999, AstraZeneca PLC is a British-Swedish pharmaceutical and biotechnology company headquartered at the Cambridge Biomedical Campus in Cambridge, England. The company focuses on the research, manufacturing, and sales of pharmaceutical and medical products across eight therapeutic areas: gastrointestinal, oncology, cardiovascular, respiratory, central nervous system, pain control, anaesthesia, and infection. AstraZeneca's core mission is to push the boundaries of science to deliver life-changing medicines, with a vision to transform the lives of patients through innovative solutions.
Notable figures associated with AstraZeneca include its leadership team and board members who have driven significant advancements in the pharmaceutical industry. The company has garnered substantial investment from global markets, being publicly traded on multiple stock exchanges including LSE, Nasdaq Stockholm, and Nasdaq. Key achievements include the development of the Oxford-AstraZeneca COVID-19 vaccine, which has had a profound global impact during the pandemic. AstraZeneca continues to influence the healthcare sector through its commitment to scientific excellence and its diverse pipeline of projects aimed at addressing unmet medical needs.
Companies similar to AstraZeneca include GSK, Astellas Pharma, Bayer Pharmaceuticals and Viatris.
AstraZeneca was founded in 1999.
AstraZeneca's headquarters is located in Cambridge, Cambridgeshire, GB.
AstraZeneca's most recent funding round was for $2.3B (USD) in February 2023.
As of Feb 28, 2023, AstraZeneca has raised a total of $3.8B (USD).
AstraZeneca has 83,500 employees as of Feb 6, 2024.
Bayer Pharmaceuticals
bayer.com
